Dime Commercial Bancshares, Inc. (DCOM) Market Cap & Valuation Ratios
Dime Commercial Bancshares, Inc. (DCOM) has a market cap of $1.9B, a trailing P/E of 15.4 and a price-to-sales ratio of 3.9, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DCOMDime Commercial Bancshares, Inc.Follow DCOM — free
—
Price chart with a free account
- Market cap
- 1.9B
- P/E TTM
- 15.4
- Dividend yield
- 2.3%
- 52-week
- —
- Next earnings
- 19 Jan, in 87 days
Peers
banks - regional · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | P/B | ROE | Div. yield | Rev. growth |
|---|---|---|---|---|---|---|
| DCOM | 1.9 | 15.4 | 1.24 | 9% | 2.3% | +37% |
| TBBK | 2.1 | 9.6 | 2.94 | 30% | — | +5% |
| CHCO | 2.0 | 15.5 | 2.47 | 17% | 2.5% | +7% |
| BLX | 2.0 | — | 1.18 | 14% | 4.6% | -2% |
| GABC | 1.9 | 13.4 | 1.58 | 12% | 2.4% | +29% |
| FSUN | 1.9 | 39.9 | 1.01 | 3% | 1.8% | +28% |
| RBCAA | 1.8 | 14.2 | 1.55 | 12% | 2.0% | +0.5% |
| HOPE | 1.8 | 14.1 | 0.78 | 6% | 4.0% | +29% |
| STBA | 1.8 | 13.4 | 1.27 | 10% | 2.8% | +8% |
| BY | 1.7 | 11.6 | 1.33 | 12% | 1.1% | +10% |
| NBHC | 1.7 | 17.9 | 1.04 | 7% | 3.2% | +12% |
| Median of these 10 | 14.1 | 1.30 | 12% | 2.5% | +9% |
P/E 15.4 vs. a peer median of 14.1; P/B 1.24 vs. 1.30. DCOM's own P/E sits at the 61st percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesBLX has no P/E (earnings not positive) and is left out · hover or tap a dot for values.
Dime Commercial Bancshares, Inc. — questions
- What is Dime Commercial Bancshares, Inc.'s market cap?
- $1.9B.
- What is Dime Commercial Bancshares, Inc.'s P/E ratio?
- 15.4 on trailing twelve-month earnings to 2026-06-30.
- What is Dime Commercial Bancshares, Inc.'s price-to-sales ratio?
- 3.9.
Every figure on this page comes from Dime Commercial Bancshares, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.